SAN DIEGO, Jan. 3, 2002 (PRIMEZONE) -- Women First HealthCare, Inc. (Nasdaq:WFHC) today announced that chairman, president and CEO Edward F. Calesa will present at The Fourth Annual Needham & Company Growth Conference. The Conference will be held Tuesday, January 8 through Thursday, January 10, 2002 at the New York Palace Hotel in New York City.
Mr. Calesa's presentation is scheduled for Thursday, January 10, 2002, from 1:00-1:30 PM Eastern Time and will include discussion of business operations and strategic plans for the company.
During the three-day Conference, over 200 companies including pharmaceuticals, health care, software and information technology are scheduled to present.
Mr. Calesa's presentation at The Fourth Annual Needham & Company Growth Conference will be available to all interested parties through a live audio webcast with slides on Thursday, January 10, 2002 at 1:00 PM Eastern Time via Wall Street Webcasting at http://twst.com/econf/mm/needham/wfhc.html. The presentation can also be accessed through the Company's website at www.womenfirst.com (Investor Relations, Interviews/Presentations area). Windows Media Player is the required software plug-in, and a link to easily download a free version of the plug-in is available within the womenfirst.com Investor Relations, Interviews/Presentations area. After the Conference on Thursday, January 10, Mr. Calesa's Needham & Company presentation webcast will be archived for on-demand viewing on both websites for sixty days.
About Women First HealthCare, Inc.
Women First HealthCare, Inc. (Nasdaq:WFHC) is a San Diego-based specialty pharmaceutical company. Founded in 1996, its mission is to help midlife women make informed choices regarding their health care and to provide pharmaceutical products -- the Company's primary emphasis -- and lifestyle products to meet their needs. Women First HealthCare is specifically targeted to women age 40+ and their clinicians. An internationally recognized Health Advisory Board of experts in women's health guides Women First HealthCare in the development of information and products for women and clinicians as women transition from perimenopause through postmenopause. The Company operates in three segments: Pharmaceuticals, Consumer Business, and Corporate Marketing. Product focus currently includes estrogen replenishment, headache/pain management, antibacterial/urinary tract infection management, dietary supplementation and self-care/lifestyle. Further information about Women First HealthCare can be found online at www.womenfirst.com, About Us and Investor Relations. Information about the Company's As We Change(r) national mail order catalog and Internet retailer can also be found online at www.aswechange.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to various risks, and Women First HealthCare, Inc. cautions you that any forward-looking information is not a guarantee of future performance. Women First HealthCare, Inc. disclaims any intent or obligation to update these forward-looking statements. Actual results could differ materially due to a number of factors, including (i) we have incurred significant losses since we were founded in November 1996, and if midlife women do not use, and their clinicians do not recommend, the products we offer, we will continue to experience losses; (ii) there is a limited market awareness of our Company and the products and services we offer; (iii) we may not be able to identify appropriate licensing, co-promotion or acquisition candidates in the future or to take advantage of the opportunities we identify; (iv) we and our products face significant competition; (v) if we do not successfully manage any growth we experience, we may experience increased expenses without corresponding revenue increases; (vi) we are dependent on single sources of supply for all of the products we offer; (vii) reduced consumer confidence could adversely affect sales by our Consumer Business Division; and (viii) additional factors set forth in the Company's Securities and Exchange Commission filings including its Annual Report on Form 10-K for the period ended December 31, 2000 and its Form 10-Q for the period ended September 30, 2001.